Wednesday, December 13, 2017 12:22:07 PM
https://www.otcmarkets.com/stock/EVIO/news
Obviously it's just fluff until execution, however, EVIO is really trying to get away from those damn toxic notes.
They are looking to raise $3M in convertible funding. The key here is that it's different from toxic notes as there is a static price set for the conversion and it is over a much longer term 36 months.
Guess we'll see what kind of money they can raise but this would be a major change in our stock. We would not see any dilution for years on this funding.
Also if successful, I would hope they immediately pay off any current open convertible notes and uplist to QX. This venture would 'print' 5 Million new shares.... but not for another 3 years.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM